Researches

South Egypt Cancer Institute

Assiut University

# Title Department Research Member Research Year
11 Prognostic Value of Vitamin D Receptor in Patients with Metastatic Colorectal Cancer Received Irinotecan-Based Systemic Treatment as a Second Line Department of Medical Oncology Prof. Ashraf Zeidan Abdalla Ahmed 2024
12 Prognostic Value of Vitamin D Receptor in Patients with Metastatic Colorectal Cancer Received Irinotecan-Based Systemic Treatment as a Second Line Department of Medical Oncology Dr. Amen Hamdy Zaki Ali 2024
13 The transcription factor ZEB-1 conveys chemoresistance in breast cancer Department of Medical Oncology Samar Abotaleb Mahmou 2024
14 Role of Irreversible Electroporation in Solid Abdominal Tumors Management Department of Radiology Dr. Doaa Mohamed Fouad Mahmoud 2024
15 Tumor Lymphocytic Infiltration as a Prognostic Factor in Gastric Carcinoma Department of Medical Oncology Sanaa Saber Abdelraheem Barakat 2023
16 Value of FoxO3a Gene Expression in Pediatric Acute Lymphoblastic Leukemia Department of Clinical Pathology Dr. Doaa Fathi Hagag Ahmed 2023
17 CD44 as a prognostic marker in early colorectal cancer: single center experience “South Egypt cancer institute”, Egypt Department of Medical Oncology Amany Nasr Ahmed Mohammed Elemary 2023
18 Value of FoxO3a Gene Expression in Pediatric Acute Lymphoblastic Leukemia Department of Clinical Pathology Prof. Rania / Mohamed Mohamed / Bakri / El-Aton 2023
19 FOXP3 Expression as a Biomarker in Metastatic Colorectal Cancer Treated with Irinotecan-based Therapy Department of Medical Oncology Dr. Salah Mabrouk Khallaf Abd Rabou 2023
20 FOXP3 Expression as a Biomarker in Metastatic Colorectal Cancer Treated with Irinotecan-based Therapy Department of Medical Oncology Amany Mohammed Abdel Moatamed 2023